Owlet (OWLT) Operating Leases (2022 - 2023)
Owlet (OWLT) posted quarterly Operating Leases of $1.2 million for Q4 2023, up 2.5% year-over-year from $1.2 million in Q4 2022, and up 1554.17% quarter-over-quarter from $72000.0 in Q3 2023.
Owlet (OWLT) Operating Leases (2022 - 2023) Analysis & Trends
Owlet (OWLT) has reported Operating Leases for 2 consecutive years, with $1.2 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Operating Leases rose 2.5% year-over-year to $1.2 million; the TTM figure through Dec 2023 stood at $1.2 million (up 2.5% YoY), while the FY2023 annual figure was $1.2 million, up 2.5% from the prior year.
- Operating Leases rose to $1.2 million in Q4 2023 per OWLT's latest filing, from $72000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $3.4 million in Q1 2022 and bottomed at $72000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Owlet | 159.40 Mn | 122.85 Mn | 21.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 715,000.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 3.44 Mn |